Service Corporation International (SCI) UBS Global Healthcare Conference 2025 summary
Event summary combining transcript, slides, and related documents.
UBS Global Healthcare Conference 2025 summary
13 Jan, 2026Key business trends and performance
Funeral and cemetery volumes have normalized, with volatility reduced and foundational strength expected to continue.
Cremation mix shift has moderated to a 50-100 basis point annual increase, down from previous higher rates.
SCI Direct experienced more volatility than anticipated due to operational shifts and transition to insurance products.
Cemetery segment posted 10% growth in the third quarter, exceeding earlier cautious expectations.
Pre-need cemetery sales remain strong, with Baby Boomer demographic expected to drive future growth.
Financial outlook and growth drivers
EPS growth target of 8%-12% for 2026, driven by stable funeral volumes, low single-digit revenue growth, and capital deployment.
Capital deployment includes $75-$125 million in acquisitions, growth capital, and share buybacks.
Interest rates expected to be flat or decline by 2026; tax rate headwinds from expiring deductions are factored in.
Transition to insurance products in SCI Direct is complete, expected to support funeral production growth.
Acquisitions contribute 1%-2% to growth, with synergies typically realized within 12-18 months.
Market dynamics and demographic trends
Funeral volumes are stabilizing, with COVID impacts moderating and Baby Boomer effects expected later in the decade.
Average client age is 80-81, with Baby Boomer impact on volumes likely to be more pronounced in the late 2020s.
Pre-need cemetery penetration is around 20%-25% for the target age group, indicating further growth potential.
Cremation rates are at 57% and expected to plateau around 75%, with the pace of increase moderating.
Revenue per case for burial and cremation is growing at inflationary rates, with limited pricing power due to market fragmentation.
Latest events from Service Corporation International
- Urban network, pre-need backlog, and tech-driven efficiency fuel growth and future outlook.SCI
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - Adjusted EPS rose 8% in Q4 and 9% for the year, with 2026 guidance targeting further growth.SCI
Q4 202513 Feb 2026 - Earnings growth, robust M&A, and tech-driven efficiency position the business for strong future gains.SCI
Raymond James & Associates’ 46th Annual Institutional Investors Conference 20253 Feb 2026 - Normalized growth, margin expansion, and evolving cremation trends shape the outlook.SCI
BofA Securities Leveraged Finance Conference 20253 Feb 2026 - Q2 revenue up, adjusted EPS down; strong cash flow and capital returns; guidance at lower end.SCI
Q2 20242 Feb 2026 - Q3 2024 delivered stable profits, strong cash flow, and record acquisitions for future growth.SCI
Q3 202417 Jan 2026 - Strong market position, robust cash flow, and strategic growth drive superior shareholder returns.SCI
Investor presentation13 Jan 2026 - Strong market position, robust returns, and growth driven by scale and preneed strategy.SCI
Investor presentation13 Jan 2026 - Industry leader with strong cash flow, superior returns, and 2025 EPS growth aligned with targets.SCI
Investor presentation13 Jan 2026